Interne link ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10 april 13, 2021 om 08:15 PM UTC
Interne link ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares april 05, 2021 om 08:15 PM UTC
Interne link ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 april 02, 2021 om 08:15 PM UTC
Interne link ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares maart 31, 2021 om 02:25 AM UTC
Interne link ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares maart 30, 2021 om 08:05 PM UTC
Interne link ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials maart 24, 2021 om 11:00 AM UTC
Interne link ProQR to Present Results from Phase 1/2 Trial of QR-421a for Usher Syndrome maart 17, 2021 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference maart 02, 2021 om 09:30 PM UTC
Interne link ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results februari 25, 2021 om 12:00 PM UTC
Interne link ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome februari 16, 2021 om 09:30 PM UTC
Interne link ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10 januari 07, 2021 om 12:00 PM UTC